Better Cystic Fibrosis Treatment in One Simple Test
The best cystic fibrosis treatment is the one tailor-made for you. Is it possible? Yes, say UNC researchers.
Category: Chronic Illness
What’s the Difference Between Hepatitis A, B and C?
Understand the types of this liver disease and how to protect yourself
Chronic Illness, Hepatitis A, Hepatitis B, Hepatitis C, Hepatology, Liver Disease
UNC teams with Verily Life Sciences to study trauma recovery
The Verily Study Watch will help researchers at the UNC School of Medicine and across the country collect first-in-kind data to better understand and diagnose adverse brain outcomes after trauma.
Chronic Illness, Depression, Neurology, News, Pain, Psychiatry, PTSD, Research, Trauma, Traumatic Brain Injury
ALS: New Clues to the Cause and How Future Drugs Might Reverse Disease
UNC and NC State researchers team up to reverse TDP-43 protein aggregation, a hallmark of degenerative diseases.
Study shows meetings with palliative care clinicians offer no addit...
The research published in JAMA also found that ICU clinicians provided adequate communication, information.
On Auto Attack
Our own immune cells can destroy other healthy cells to cause severe and chronic diseases. Maureen Su, MD, a 2014 Jefferson-Pilot award winner, studies how this autoimmunity happens and what it might tell us about potential cancer therapies.
Jeff Mazza: A New Kidney, A New Life
A former Chapel Hill dentist now retired in Carteret County gets a second chance at life thanks to the donation of a kidney from his adult son.
Fearing pain and avoiding activities contribute to disability and c...
New research from the University of North Carolina School of Medicine suggests that fear avoidance contributes to disability and pain in children with Functional Abdominal Pain (FAP) but not Inflammatory Bowel Disease (IBD).
Spurred by food allergies, two esophagus conditions stump doctors
Researchers at the UNC School of Medicine found that two on-the-rise esophagus conditions are so similar that even a biopsy is not enough to distinguish one disease from the other.
New gene therapy proves promising as hemophilia treatment
Researchers package specialized blood platelets with genes that express clotting factor, leading to fewer bleeding events.
FDA, academia and industry team up to end hepatitis C
The Hepatitis C Therapeutic Registry and Research Network, or HCV-TARGET, is led jointly by investigators at the University of North Carolina School of Medicine and University of Florida and is sponsored in part by multiple pharmaceutical companies.
Persistent pain after stressful events may have a neurobiological b...
A new study led by University of North Carolina School of Medicine researchers is the first to identify a genetic risk factor for persistent pain after traumatic events such as motor vehicle collision and sexual assault.